ABSTRACT PAP248-286 is a 39-residue fragment (residues 248 to 286) derived from protease cleavage of prostatic acidic phosphatase in semen. The amyloid fibrils formed in vitro by PAP248-286 can dramatically enhance human immunodeficiency virus (HIV) infection. To our knowledge, we present the first report that the HIV-enhancing potency of fibrils formed by PAP248-286 is morphology dependent. We identified pleomorphic fibrils by transmission electron microscopy in two buffer conditions. Our solid-state NMR data showed that these fibrils consist of molecules in distinct conformations. In agreement with NMR, fluorescence measurements confirmed that they are assembled along different pathways, with distinct molecular structures. Furthermore, our cell-based infectivity tests detected distinct HIV-enhancing potencies for fibrils in distinct morphologies. In addition, our transmission electron microscopy and NMR results showed that semen-derived enhancer of viral infection fibrils formed in sodium bicarbonate buffer remain stable over time, but semen-derived enhancer of viral infection fibrils formed in phosphate buffered saline keep evolving after the initial 7 days incubation period. Given time, most of the assemblies in phosphate buffered saline will turn into elongated thin fibrils. They have similar secondary structure but different packing than thin fibrils formed initially after 7 days incubation.
INTRODUCTION
Predominantly, acquired immunodeficiency syndrome (AIDS) infections are transmitted via sexual intercourse (1) . However, the efficiency of human immunodeficiency virus (HIV) sexual transmission is surprisingly low, i.e., only one out of 200-2,000 coital acts results in infection (2) . In addition to the concentration of virus particles in the ejaculates, semen itself is an important modulator of HIV transmissibility. However, the effect of semen on HIV infection is still debated, because it contains both viral-enhancing (3) (4) (5) (6) (7) (8) (9) (10) (11) and -inhibiting factors (7, 8, 12, 13) . Recently, a potent HIV-enhancing factor was discovered by screening proteins in semen. PAP248-286 is the most populated fragment derived from protease cleavage of the prostate acidic phosphatase (PAP) (3), a protein present in human semen at mg/mL concentration (14) . At high concentration, PAP248-286 assembles in vitro into amyloid fibrils if shaken vigorously (3) . These fibrils can enhance HIV up to 100,000 times, and thus are called semen-derived enhancer of viral infection (SEVI) (3) . Such a potent modulator of HIV infection can dictate the role of semen in HIV sexual transmission.
The original in vitro fibrillization condition for SEVI requires 1400 rpm shaking for 7 days in phosphate buffered saline (PBS) buffer, which is far from any physiologically relevant conditions. Recently, similar SEVI were shown to form in seminal plasma (SP) at an accelerated rate without agitation by Olsen et al. (5) , due to the presence of anionic buffer components such as sodium bicarbonate. In addition, they also demonstrated that a high concentration of Zn 2þ in SP protects SEVI fibrils from seminal proteases (5) , which addressed concerns that SEVI fibrils, even if they do form in semen, could be digested by protease in SP (15) . More recently, Usmani et al. (16) were able to directly identify amyloid fibrils containing PAP248-286 in semen by confocal, transmission electron microscopy (TEM) and atomic force microscopy (AFM), these fibrils exhibited a similar level of HIV-enhancing potency as in vitro SEVI. This finding lends support to the clinical significance of SEVI.
Currently, the mechanism and structural basis of SEVI is poorly understood. Solution NMR studies indicated that monomeric PAP248-286 is disordered in the soluble state (17) and assumes a highly helical structure in trifluoroethanol (TFE) solution (18) . Münch et al. (3) found that the ability to enhance HIV infection was imparted only after PAP248-286 assembles into SEVI fibrils. These fibrils are presumably constructed by PAP248-286 molecules in cross-b structure, because they exhibit typical 4.7 and 10.6 Å x-ray diffraction rings and show enhanced fluorescence signals in thioflavin T (ThT) assay (3) . But fibrillization is not the only requirement to acquire HIV-enhancing ability for PAP248-286. Roan et al. (19) showed that mutant PAP248-286 with positively charged residues replaced by alanine still fibrillizes but abolish the ability to enhance HIV infection. To probe the fibril cores, French et al. studied the SEVI by hydrogen-deuterium exchange mass spectrometry and protease digestion assay. Their results indicate that the first 7 residues at the N-terminal region are exposed to solvent and flexible, and from residue 14 on the peptide is well protected and forms the fibril core (20) . Moreover, they found that the N-terminus truncated version of PAP248-286D1-8 and PAP248-286D1-13 fibrillize even at acidic environments (20) . Taken together, these findings suggest that cationic charges of wild-type PAP248-286 and fibrillar supramolecular structure are both essential for SEVI's ability to promote HIV infectivity. However, little is known at the molecular level about its mechanism, which may help explain apparent conflicting observations about the effect of SEVI on HIV infection. For example, current evidence implies heterogeneous HIV-enhancing potency of SEVI in semen. Specifically, although the level of PAP248-286 in semen correlates somewhat with HIV-enhancing activity of pooled semen (4), a strong donor dependence of HIVenhancing potency was observed when tested with individual semen samples (4, 16, 21) .
To our knowledge, we present the first report that the HIV-enhancing potency of SEVI is morphology dependent. With TEM, we identified fibrils of two distinct morphologies, thin (diameter~3-4 nm) and thick fibrils (diameter 7-8 nm). They can be formed in two typical in vitro conditions (3, 5) . In PBS buffer, both thin and thick fibrils are present with comparable population after 7 days incubation, whereas most of SEVI are thick fibrils in buffer containing 25 mM sodium bicarbonate and 40 mM sodium phosphate, pH ¼ 7.7 (NaBiCarb buffer). In addition, although thick fibrils formed in both buffers appear similar under TEM, our solid-state NMR (ssNMR) results showed their structures actually differ completely at molecular level. In agreement with ssNMR, fluorescence measurements suggested that the assembly of PAP248-286 molecules follows two distinctive pathways in these two conditions, resulting in a tight molecular packing of SEVI in PBS buffer and a looser tertiary/quaternary structured SEVI in NaBiCarb buffer. Most intriguingly, cell-based infectivity tests showed that the fibrils formed in NaBiCarb buffer exhibit significantly higher potency to promote HIV infection than those formed in PBS buffer. Furthermore, we found that SEVI fibrils exhibit different long-time stability. Although fibrils formed in NaBiCarb are stable over time, fibrils in PBS keep evolving as time goes by, and most of the thick fibrils initially formed get converted into thin fibrils. It suggests that thin fibrils in PBS are thermodynamically more stable compared to their thick peers in the solution. Combined, our data identify a previously unknown structural basis for the mechanism of SEVI fibrils to enhance HIV infection, which could possibly lead to the observed heterogeneous HIV-enhancing potency of SEVI in SP and donor-dependent HIV-enhancing efficacy of semen (4, 21) .
MATERIALS AND METHODS

Materials
ThT was purchased from Fisher Scientific (Pittsburgh, PA). High purity (>98%) PAP248-286 peptides (sequence GIHKQKEKSRLQGGVLV NEILNHMKRATQIPSYKKLIMY) were purchased commercially produced via solid phase peptide synthesis (EZBiolab, Carmel, IN). Isotopelabeled PAP248-286 peptide was synthesized by incorporating 13 C uniformly labeled residues at G14, V15, L16, and A27 (underscored residues in the sequence).
Preparation of SEVI fibrils
All SEVI fibril samples for TEM, ssNMR, and infectivity studies were prepared by dissolving fresh synthetic PAP248-286 peptide in PBS or NaBiCarb buffer at 5 mg/ml concentration and incubating the clear solution at 37 C while shaking at 1400 rpm for a week, as described previously in the literature (3, 5) .
TEM characterization
All images were acquired on a JEOL TEM-1011 (Peabody, MA) operated at 80 kV using carbon-coated grids (Ted Pella (Redding, CA) ultrathin carbon (thickness <3nm) on holey carbon support, product No. 1824). Images were taken with gain set to 1 with 400 ms exposure time, 5 integrations and 1024 Â 1024 pixels. To prepare TEM samples, a 5 mL droplet of the sample was deposited on a carbon film-coated grid. After 5 min, the excess volume was carefully wicked off. Immediately, 5 mL of 3% uranyl acetate solution was applied briefly and then washed twice with 5 mL distilled deionized water. Five different batches of samples were repeated for each buffer condition and six TEM samples were analyzed for each sample to confirm the reproducibility of the observations.
SsNMR measurements
SEVI fibrils were prepared with peptide uniformly 13 C labeled at G14, V15, L16, and A27 as described previously. Fibrils were pelleted down at the end of the 7 days incubation period on a tabletop centrifuge for 1 h. The hydrated pellets at the bottom of centrifuge tubes were then packed into 3.2 mm thin-wall magic-angle spinning (MAS) rotors for NMR experiments. SsNMR spectra were acquired on a 600 MHz Bruker spectrometer (Billerica, MA) at National High Magnetic Field Laboratory (NHMFL) and a 600 MHz Agilent spectrometer with 3.2 mm low electric-field MAS probes. Sample temperature was maintained at~10 C with a stream of cooled gas via variable temperature. The 2D 13 C-13 C correlation spectra were acquired with 25 and 100 ms of dipolar-assisted rotational resonance (DARR) mixing (22) 
Fluorescence characterization
ThT assay
Fresh PAP248-286 peptide was dissolved at 5 mg/ml. Samples were then incubated at 37 C with constant shaking at 1400 rpm. For fluorescence measurements during incubation, 10 mL peptide solution was pipetted out and diluted to 0.2 mg/ml in a 240 mL quartz cuvette with 25 mMol ThT for ThT binding assay. The ThT fluorescence was measured using a Jasco J-810 spectropolarimeter (Easton, MD) with a fluorescence attachment. Emission spectra were recorded between 400-600 nm at 37 C with
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Tyrosine fluorescence
Tyrosine fluorescence was measured immediately following ThT fluorescence using the same batch of solutions. Emission spectra were recorded from 270 to 370 nm at 37 C with excitation at 275 nm.
Cell lines and viruses
The Cell supernatants were clarified by centrifugation followed by filtration through a 0.45 mm syringe filter, and stored at À80 C in aliquots to be used as virus stocks. Quantification of viral stocks was performed using an HIV-1 p24 enzyme-linked immunosorbent assay (ELISA) kit (Perkin Elmer, Waltham, MA). Viral titer was determined by infecting PM1 and TZM-bl cells with serial dilutions of viral stock, and identifying the dilution that resulted in infection of 50% of the culture wells (TCID 50 /mL).
Antiviral and cytotoxicity assays
To determine which fibril arrangement may impart greater effects on HIV infection, we used the well characterized TZM-bl reporter assay (12, (27) (28) (29) . The TZM-bl HIV target cells were plated at 6000/well in 96-well dishes and left to incubate overnight at 37 C/5% CO 2 . The next day, maintenance media was aspirated and replaced with 50 mL of serum-free DMEM containing either of vehicle (PBS or NaBiCarb buffer), soluble PAP248-286 peptide, SEVI fibrils prepared in PBS, or SEVI fibrils prepared in NaBiCarb buffer. Peptides were administered at 8.75-70 mg/mL (twofold serial dilutions), because 35 mg/mL has been shown to be physiological (3). After 15 min, HIV-1 BaL was diluted in DMEM/20% FBS and administered to the pretreated cells (50 mL/well) at a final concentration of 60 TCID 50 /0.1 mL (MOI ¼ 0.01) for virus, and DMEM/10% FBS for culture media. Infections were carried out for 24 h at 37 C/5% CO 2 , after which cells were lysed and processed for luciferase assay (Bright Glo, Promega, Madison, WI). Relative luciferase units were acquired using an LMax luminometer (Molecular Devices, Sunnyvale, CA) with a 5 s integration time per well. Statistical analyses were performed using GraphPad Prism 5 (GraphPad Software, Inc., La Jolla, CA). Viral enhancement assays of PAP248-286 at different concentrations were analyzed by two-way analysis of variance with Bonferroni posttests to compare luciferase levels from each fibril preparation versus soluble PAP248-286 peptide or to compare SEVI formed in NaBiCarb versus SEVI formed in PBS.
TZM-bl assay findings were confirmed using PM1 cells, which can host and propagate HIV without the use of adjuvants such as DEAE-dextran or polybrene that are often required for infecting primary peripheral blood cells in vitro. PM1 cells (1.5 Â 10 5 ) were incubated with 35 mg/mL soluble PAP248-286, SEVI fibrils formed in PBS, or in NaBiCarb, or plain PBS (volume-matched control) for 10 min before infection with HIV-1 BaL (150 TCID 50 /0.1 mL, MOI ¼ 0.001) for 1 h. Cells were then washed to remove excess virus, resuspended in growth media containing the appropriate treatment, and left to incubate for 2 days. Propagated HIV was measured by p24 ELISA of collected cell supernatants, and normalized to the number of live PM1 cells present at the collection time. Cell viability was monitored by trypan blue exclusion. Paired t-tests were used to directly compare levels of propagated HIV between each SEVI preparation and soluble PAP248-286, or to compare SEVI formed in NaBiCarb versus SEVI formed in PBS.
RESULTS
Coexistence of thin and thick fibrils identified by TEM
Freshly synthesized PAP248-286 peptide was dissolved at 5 mg/ml concentration in PBS and NaBiCarb buffers, respectively. No preexisting fibrils were present in the freshly dissolved solution as inspected by TEM. The clear transparent solutions were then incubated at 37 C while shaking at 1400 rpm for 7 days, as described previously (3, 5) . During this time, NaBiCarb solution became turbid after a day, whereas PBS solution became cloudy after several days (R3 days). Fibrils started to appear in both solutions, as images taken after 3 days incubation shown in Fig. 1 , A and D. After a week of incubation, both solutions became opaque. At this point, both thin fibrils and thick fibrils were present. Fig. 1 , B and E, show images of thin fibrils in PBS and NaBiCarb buffers, respectively. Their diameters are around 3-4 nm. Images of thick fibrils in PBS and NaBiCarb buffers are shown in Fig. 1 , C and F, with diameters around 7-8 nm. The population of thin fibrils is slightly more than that of thick fibrils in PBS buffer in TEM. This agrees with the presence of two distinct sets of resonances for each carbon site in our NMR spectrum taken immediately after 7 days incubation, see Fig. 3 A. This indicates that thin and thick fibrils consist of molecules in distinct conformations. In contrast, thin fibrils are rather rare in NaBiCarb buffer and only present in the less turbid top layer of the solution, as shown in the Supporting Material (Fig. S1) . We estimate the population of thin fibrils is 10% of thick fibrils in NaBiCarb. Two scenarios are possible to explain this observation. First, thin fibrils in NaBiCarb buffer consist of molecules in different conformation with less density, a different species than the more populated thick fibrils. Alternatively, these thin fibrils are in fact the precursory form of thick fibrils in NaBiCarb buffer, they proceed to further associate together into heavier form and precipitate to the bottom. The latter seems to be consistent with our NMR data, because a unique set of signals for each carbon site appear in ssNMR spectrum, see Fig. 3 B.
Furthermore, SEVI fibrils formed in NaBiCarb buffer appear stable and do not change their morphology beyond the initial 7 days incubation, as shown in at room temperature. Given more time, thin fibrils in PBS buffers gradually grew longer without increasing their diameter, as shown in Fig. S1 , A and B. This evolution in morphology seems to be accompanied with structural variation at molecular level (see Fig. 3 ) by NMR spectra acquired 1 year after the fibrils were prepared by 7 days incubation. To confirm the observed changes in NMR spectra, we opened the NMR rotor that contains SEVI fibrils formed in PBS buffer a year ago. The fibrils were briefly resuspended in PBS buffer and their TEM images are shown in Fig. 2 . Most of the thick fibrils disappeared and a majority of the fibrils were bundled long and thin fibrils, consistent with changes manifested in our NMR spectra.
Polymorphism of SEVI at molecular level by ssNMR
SsNMR measurements were performed on SEVI fibrils formed in PBS and NaBiCarb buffers, respectively, to probe their underlying molecular structures at site-specific resolution. PAP248-286 peptide used for the NMR fibril samples was uniformly 13 C labeled at positions G14, V15, L16, and A27, as explained in the Methods section. The labeling positions were chosen to sample regions with different fibrillization propensities (30) , where residues 14-16 were expected to be the beginning region of fibrillar core (20) , and A27 was at the region with low fibrillization propensity according to theoretical predictions. 
2D
13 C-13 C correlation spectra for fibril samples prepared in PBS and NaBiCarb buffers are shown on the left and right in Fig. 3 , respectively. Spectra at the top row of Fig. 3 were acquired immediately after the 7 days incubation process, and spectra at the bottom row were acquired 1 year after samples packed into NMR rotors. Consistent with the mixed morphologies in TEM, there are two distinct sets of resonances (labeled as A and B) for each carbon site in Fig. 3 A for fibrils prepared in PBS immediately after 7 days incubation. Both exhibit very sharp signals with line width~0.8-1.2 ppm. Fibrils prepared in NaBiCarb buffer show a slightly broader signal with linewidth~1.5 ppm in Fig. 3 B. Representative one-dimensional slices at 50.5 and 49.18 ppm for Ala Ca-Cb crosspeaks are shown in Fig. 3 , A and B. The broader linewidth in Fig. 3 B suggests molecules in fibrils formed in NaBiCarb buffer are less ordered than those in PBS buffers. Nonetheless, the linewidth of both samples are comparable to those with defined order, such as the amyloid fibrils formed by Ab 1À40 peptide in Alzheimer's disease (31) (32) (33) (34) (35) (36) . These data indicate that SEVI fibrils of all morphologies are constructed by well-ordered molecular structure in both conditions. The only exception is that G14 in set B in Fig. 3, A and B . The Ca signal spreads along the diagonal direction over 4 ppm range, from~42.6 to 38 ppm, suggesting rather disordered conformations for this residue.
With sharp linewidth, all signals in NMR spectra are assigned in both spectra. The assignments are listed in Tables S1 and S2. In Fig. 3 A, each labeled carbon site for SEVI in PBS buffer exhibits two sets of signals A and B. This agrees with the heavy mixture of thick and thin fibrils in our TEM observations in PBS buffer. It reveals that SEVI fibrils of different morphologies actually consist of molecules in two different conformations. Furthermore, the population ratio of fibrils of different thickness can be roughly estimated by the crosspeak intensity between set A and B, which is~3:2, consistent with the slight more favorable population of thin fibrils in PBS buffer under TEM. 
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On the other hand, only one set of signals is present for nearly all 13 C-labeled sites for SEVI fibrils in NaBiCarb buffer, as shown in Fig. 3 B. The unique set of NMR resonances in Fig. 3 B proves that there is only one structure in NaBiCarb buffer, and suggests that thin fibrils are probably precursory assembly for thicker fibrils. The only exception is A27, where a minor Ca-Cb crosspeak is present. For A27, the intensity ratio for the strong and weak Ca-Cb crosspeaks is~2.14, suggesting A27 adopts two different and defined conformations in fibrils.
According to the well-established correlation between secondary structure and NMR signal position (chemical shift) (37, 38) , signals in Fig. 3 indicate that nearly all labeled sites in these fibrils are in b-strand conformation. Usually secondary shifts are calculated by subtracting random coil values from observed chemical shifts of C 0 , Ca, and Cb for secondary structure prediction. The secondary shift analysis of corresponding residues is plotted in Figs. S3-S5. This agrees well with the hydrogen-deuterium exchange results that the fibrillar core extends from residue G14 to its C-terminus in the peptide (20) . In addition, despite the similar appearance in TEM images for thick fibrils in both buffers, the differences in NMR chemical shifts for C 0 , Ca, and Cb of all residues are generally larger than 1.5 ppm, which suggests that thick fibrils in different buffers actually consist of molecules in distinct conformations.
To further test the evolution of fibril morphology observed in TEM, we took NMR spectra of both samples 1 year after the samples were prepared. During this 1 year, NMR samples were stored at quiescent condition at room temperature. No changes were identified in NMR spectra for SEVI fibrils prepared in NaBiCarb buffers. To better differentiate inter and intraresidue crosspeaks, a 25 ms DARR spectrum for SEVI fibrils in NaBiCarb sample was also acquired at the same time and is shown in Fig. 3 D. The strong signals in Fig. 3 D agree well with sites at onebond distance away and their positions are identical to those in Fig. 3 B, supporting our TEM observation with no structural variation over the extended time period. Two interresidue crosspeaks between L16 and V15 are present in Fig. 3 B but absent due to shorter mixing time in Fig. 3 D, as highlighted by circles in Fig. 3 B. On the other hand, spectra acquired after 1 year for SEVI samples in PBS buffer indicate structural evolution at molecular level over a long time. 100 ms and 25 ms DARR mixing spectra acquired 1 year after the sample was packed are shown in Figs. 3 C and S6 . First of all, resonances corresponding to B set signals (thick fibrils) exhibit much attenuated intensity compared to their counterparts in Fig. 3 A. For example, all intraresidue crosspeaks for V15B are much weaker, and those for L16B and A27B are almost invisible. On the other hand, most of the resonances corresponding to A set signals (thin fibrils) remain unchanged and strong with the exceptions for crosspeaks involving Cb of L16A. Although signals at positions corresponding to L16A Cb in Fig. 3 A remain still visible with attenuated intensity in Fig. 3 C, new dominant signals appear at positions near the original positions of Cb of L16A and L16B in Fig. 3 A. This new resonance frequency is almost identical to the old Ca of G14A, and shifts toward higher frequency in comparison with L16A Cb in Fig. 3 A. We associate them with L16 Cb because they ((45, 53) and (28, 45) ppm) exhibit strong resonances in 25 ms mixing spectrum, which suggests they are intraresidue crosspeaks involving L16A Cb instead of interresidue signals involving G14 Ca. This indicates that L16A adopts a more b-sheetlike conformation. Combined, the attenuated resonances for B set of signals and largely conserved A set of signals corroborate very well with the concomitant decreasing population of thick fibrils and dominant elongated thin fibrils of the sample in TEM images. It also confirms our assignments to associate A set of signals with thin fibrils and B with thick fibrils in PBS. It suggests that secondary structure for thin fibrils is largely retained during their elongation, with a more b-sheet-like state associated with L16. In addition, all interresidue crosspeaks for A set of signals in Fig. 3 A are still present in Fig. 3 C but with much weaker intensity, and the interresidue signals for B set of signals in Fig. 3 A are completely gone. This indicates accompanied tertiary and quaternary structure variations for fibrils formed in PBS buffer over time.
Assembly kinetics tracked by fluorescence
To assess the kinetics and conformational transitions accompanying assembly, we performed fluorescence characterization. We found that PAP248-286 in PBS and NaBiCarb buffer follow distinct fibrillization pathways. Fig. 4 A shows fibrillization kinetics monitored by ThT assay over 115 h, starting with PAP248-286 peptide freshly dissolved in PBS and NaBiCarb buffers separately. For NaBiCarb buffer, the time dependence of ThT fluorescence can be described by a single exponential curve y ¼ A 0 e Àt=t , with a best fit time constant of t ¼ 3.33 h. But for fibrillization in PBS buffer, the increase of ThT fluorescence appears to be much slower than 115 h. The data points within 115 h could not be captured by a single exponential with t ¼ 336 h, as shown in Fig. 4 A. This agrees with our TEM and NMR observation that both the fibril morphology and molecular conformation keeps evolving over the time beyond the 7 days incubation period. In addition, ThT fluorescence intensity quickly reaches a significantly higher level for PAP248-286 fibrils in the NaBiCarb buffer as compared to those in PBS. This agrees with the observation of highly populated short fibrils in NaBiCarb buffer just in 3 days incubation, but much fewer fibrils in PBS buffer. Variations of ThT fluorescence intensity in the presence of different amyloid fibrils have been detected before and explained in terms of distinct ThT-fibril binding constants and stoichiometry, as well as structural differences among the fibrils Biophysical Journal 108(8) 2028-2037 (25, 26) . Although data in Fig. 4 A cannot distinguish these possibilities, they are consistent with distinct structures of SEVI fibrils in two buffers at molecular identified in our NMR spectra.
In addition, there are two tyrosines (Tyr) at the C-terminus (residues 33 and 39, bolded in the sequence shown in the Methods section) of PAP248-286. Tyr fluorescence was used to probe the changes of local microenvironments, such as solvent accessibility (39) . As shown in Fig. 4 B, Tyr fluorescence intensity significantly decreases during fibrillogenesis in NaBiCarb, whereas the change for sample in PBS buffer is much weaker and six times slower. Furthermore, fibrillization of PAP248-286 in NaBiCarb buffer is accompanied with a 3 nm red shift, although no spectral shift occurs in PBS, as shown in Fig. 4 C. The red shift over time in NaBiCarb can be described by a single exponential curve with t ¼ 27.5 h. The time constant of Tyr fluorescence intensity change in NaBiCarb is t ¼ 30.3 h, similar to that of its spectral red shift. It indicates that at least the C-terminal part of PAP248-286 molecules assumes a loose, more solvent accessible tertiary/quaternary structure in SEVI formed in NaBiCarb buffer, resulting in solvent relaxation and solvent quenching (39) . In contrast, the same region in the mixed fibrils in PBS buffer forms a more compact and solvent-protected structure. These data are consistent with our NMR data that the structures of SEVI in two buffers are different. If we assume the fibrils with loose packing in NaBiCarb buffer will lead to a more disordered molecular structure (inhomogeneous broadening for NMR signals), it also agrees with the slightly broader NMR signals for SEVI in NaBiCarb buffer as observed in Fig. 3 .
Enhancement of HIV infection by PAP248-286 fibrils
HIV infection assays on fibrils formed in PBS and NaBiCarb buffers were done immediately after 7 days incubation to determine if their differences in structure affect their ability to enhance HIV infection. The HIV reporter cell line TZM-bl produces luciferase proportional to HIV-1 inoculum, and luciferase levels were not altered by addition of PBS or NaBiCarb buffer, as shown in Fig. 5 A. Soluble PAP248-286 peptide did not impact HIV, although both fibril types promoted increased HIV infection at 10-35 mg/ml, which is reported to be physiological (3), as shown in Fig. 5 B. SEVI formed in NaBiCarb exhibited greater potency than fibrils formed in PBS buffer. To confirm these findings, fibrils were compared to soluble PAP248-286 and PBS buffer control in PM1 cells, which are capable of propagating infectious HIV virions upon a brief exposure. Cells were treated with PBS buffer or 35 mg/ml PAP248-286 10 min before administration of HIV for 1 h. Cells were then washed off to remove the excess virus and PAP248-286, and retreated with PBS or PAP248-286. At 2 days postinfection, cells were counted and assessed for viability; and propagated HIV was measured by p24 ELISA. Using an HIV MOI ¼ 0.001, only low ng/mL levels of HIV p24 were detected in cultures of PM1 target cells coincubated with PBS or soluble PAP for 2 days; however, SEVI exposure resulted in appreciably higher levels of HIV p24 in the cultures, as shown in Fig. 6 A. The enhancement of HIV infection by SEVI, though variable among the cell passages used in four replicate experiments, was remarkable considering that SEVI-treated HIV-infected PM1 cells did not proliferate to the levels of infected cells coincubated with PBS buffer or soluble PAP peptide, Fig. 6 B. When HIV p24 ELISA values were normalized to live cell number at the time of harvest, it became evident that SEVI formed in NaBiCarb was more proviral than SEVI formed in PBS, as shown in Fig. 6 C. Pairwise comparisons of the PAP treatments versus buffer control showed that SEVI in NaBiCarb enhanced HIV infection by 900% and was almost twice as potent as SEVI formed in PBS, as shown in Fig. 6 D. 
DISCUSSION
Previously, characterizations of SEVI morphology by TEM (3, 5, 19, 21, 40, 41) and AFM (20, 42) have been reported. To our knowledge, we present the first report of the structural characterization at molecular level and prove that the Our TEM images identified SEVI fibrils with distinct morphologies, thin and thick fibrils, present in both preparation methods. Although fibrils of similar diameters in different buffers appear indistinguishable under TEM, ssNMR suggested that their structures differ at molecular level, with an average difference of chemical shift larger than 1.5 ppm. Furthermore, we showed that thin and thick fibrils in PBS buffers actually consist of molecules in different conformation, manifested by their distinct NMR chemical shifts. In contrast, the much less populated thin fibrils in NaBiCarb buffers appear to be an on pathway product for the thick fibrils, because only a unique set of NMR signal for each labeled site was identified. In addition, fibrils in PBS still evolve after 7 days incubation as our TEM and NMR results showed, consistent with the continuous increasing fluorescence in its ThT assay in the first 115 h. In contrast, the fibrils in NaBiCarb remain unchanged once formed after 7 days incubation.
Although two distinct sets of resonances are present in spectra of fibrils prepared in PBS buffer, the concomitant changes of fibril morphology in TEM images help to associate them unambiguously with different fibrils. However, assignments of two resonance signals in Fig. 3 A remain to be further tested in the future. They are crosspeak at (33.5, 44 ) ppm assigned to Cb of V15 in set B and Cb of L16 in set A, and crosspeak at (44, 60.5) ppm assigned to Ca of V15 in set B and Cb of L16 in set A. They are the most reasonable assignments given current knowledge. These two crosspeaks were only present in Fig. 3 A acquired immediately after 7 days incubation and disappeared in spectrum acquired a year later in Fig. 3 C. They indicate close proximity of V15 in thick fibrils with L16 in thin fibrils. This is only possible if two fibrils were actually physically entangled. Our TEM observation showed that most fibrils were eventually converted to thin fibrils, which implies continuous disassembly of thick fibrils to rearrange into thin fibrils. Thus, the possibility for thin and thick fibrils to be at close proximity cannot be ruled out. Further FIGURE 6 Augmented proviral effect of SEVI formed in NaBiCarb. PM1 cells were exposed to 35 mg/mL soluble PAP peptide, SEVI formed in PBS, SEVI formed in NaBiCarb, or plain PBS (volume-matched control) for 10 min and then infected with HIV-1 BaL, as described in Materials and experiments would be necessary to consolidate this indication, for example, samples prepared with a mixture of peptide 50% labeled at V15 and the other half labeled at L16. However, we note that the uncertainty of these assignments do not impact on our conclusion of this work that there are two species of fibrils with distinct morphology and viral enhancing potency. In addition, more thorough characterizations at a different times are needed to delineate the detailed time dependence of SEVI evolution in PBS.
Previously, solution NMR measurements indicated that PAP248-286 assumes disordered structure in micelles (17) and exhibits helical tendency in TFE solution (18) . We note that their results were obtained with soluble samples, not fibrils. Therefore, their structural models are for PAP248-286 in the unfibrillized state, not directly related to SEVI fibrils or the HIV-enhancing effect. Earlier results also showed the ability of PAP248-286 to induce lipid aggregation and fusion (43) , hence these disordered/helical conformations of PAP248-286 may be related to such behaviors.
In a recent report by Usmani et al., (16) endogenous SEVI fibrils were found in human semen. The thick fibrils we observed have a similar diameter to their AFM characterization (around 5-7 nm). However, the limited magnification in their TEM images make it difficult to conclude if thinner fibrils are also present in semen. Yet we cannot exclude this possibility, especially since abundant fibrils appear in their TEM images to bundle up parallel to each other, exhibiting a typical appearance that we observed for thin fibrils formed in vitro.
Our cell-based infectivity tests identify a previously unknown correlation between the morphology of SEVI fibrils and their efficacy to promote HIV infection (Figs. 5 and 6 ). Both infection assays largely depend on how many HIV particles can enter host cells during the first hours of exposure. It can therefore be surmised that thick SEVI fibrils in NaBiCarb buffer are significantly more potent to enhance viral fusion compared to those prepared in the PBS buffer. We note that the in vivo concentration of PAP248-286 has been estimated to be as high as 35 mg/ml (3), whereas our infectivity assays showed the maximum potency. This is consistent with other studies that revealed the potency of semen-enhanced infection to correlate with SEVI levels in the low mg/mL range (4). At twice the concentration (70 mg/ml), our assays revealed decreased luciferase values, which is not surprising considering that enhanced SEVImediated viral fusion could stress the target cells beyond their capacity for synthesizing luciferase, as demonstrated by Kim et al (4) . Alternatively, this finding might be related to the observed aggregation of fibrils at high peptide concentration that could lead to reduced exposed active sites per fibril strand to promote binding with virus particle; and illustrate a fine line between bridging HIV to target cells and blocking HIV from target cells. If this were true, this could be another factor contributing to the complexities of studying SEVI-mediated HIV transmission in vivo. More studies are needed to determine the composition of fresh semen samples with respect to varying concentrations of thick, thin, and aggregated SEVI fibrils.
CONCLUSION
To our knowledge, we presented here the first report for the morphology-dependent potency to enhance HIV infection of SEVI fibrils by TEM, ssNMR, and fluorescence measurements. Our spectroscopy data consistently show that PAP248-286 molecules form amyloid fibrils of distinct morphologies that consist of molecules in different conformations assembled along different pathways. Furthermore, these distinct SEVI fibrils exert different efficacies of HIV-enhancement. Our results suggest that the difference in reported potencies of SEVI fibrils to promote HIV infection may be due to the different SEVI fibrils present in test samples (15, 16) , which could explain the donor-dependent HIV-enhancing potency of semen (16) . Furthermore, we also showed that fibrils formed in PBS buffer undergo morphological variations beyond 7 days incubation. Most assemblies will eventually be converted to long and thin fibrils. They have similar secondary structure to the thin fibrils produced immediately after 7 days incubation, and exhibit different overall folding.
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